Related Experiment Videos
Maternal phenylketonuria. A study from the United Kingdom
1Department of Medicine, Rayne Institute, London, UK.
European Journal of Pediatrics
|July 1, 1996
Summary
Preconception dietary control in phenylketonuria pregnancies significantly reduced congenital heart defects. However, intermittent high or low phenylalanine levels may still impact fetal development, necessitating caution.
Area of Science:
- Metabolic disorders
- Maternal health
- Fetal development
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder requiring strict dietary management.
- Maternal PKU can lead to adverse fetal outcomes, including developmental issues and congenital anomalies.
- Previous studies highlighted risks associated with uncontrolled phenylalanine levels during pregnancy.
Purpose of the Study:
- To evaluate the impact of preconception dietary control on pregnancy outcomes in women with phenylketonuria (PKU).
- To analyze phenylalanine (Phe) control levels during pregnancy and their correlation with fetal health.
- To assess long-term neurodevelopmental outcomes in offspring of mothers with PKU.
Main Methods:
- Retrospective analysis of 39 completed pregnancies in mothers with PKU.
- Comparison of outcomes between post-conception dietary control and preconception controlled diets.
- Weekly Guthrie assays for maternal phenylalanine (Phe) levels, analyzed by trimester.
- Developmental assessment scores at 1 year and neurodevelopmental assessment at 4 years.
Main Results:
- Two offspring from post-conception control died of congenital heart disease; one required surgery for coarctation.
- No heart defects were observed in 34 offspring from 33 pregnancies with preconception dietary control.
- While generally good Phe control was achieved, intermittent high (>300 µmol/l) and low (<60 µmol/l) levels occurred.
- Developmental scores at 1 year were mostly above 100, but early 4-year assessments suggest potential intellectual impairment.
Conclusions:
- Preconception dietary control in maternal PKU is associated with a significant reduction in congenital heart defects.
- Intermittent fluctuations in maternal phenylalanine levels, even with good overall control, may pose risks to fetal development.
- Long-term neurodevelopmental outcomes require further investigation, and caution is advised when counseling PKU patients on conception.